Furthermore, mouse tumours engineered to express model antigen ovalbumin (OVA) bound to the actin‐cytoskeleton are preferentially controlled in a DNGR‐1‐dependent manner in comparison to those expressing cytoplasmic OVA [76]. The gene discussed is CLEC9A; the disease is neoplasm.